Lupin Ltd.

NSE: LUPIN | BSE: 500257

Mid-range Performer

In 1 Starfolio Basket

Download real time

2370.50 -25.80 (-1.08%)

29.06% Gain from 52W Low

736.2K

NSE+BSE Volume

NSE 24 Jul, 2026 3:31 PM (IST)

Lupin News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Lupin from all sources in a single place.

22 Jul 2026

2370.50

-1.08%

Company Update

Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Schedule of Earnings Call for Q1 FY27

22 Jul 2026

2370.50

-1.08%

Board Meeting

Lupin Ltd - 500257 - Board Meeting Intimation for Considering And Approving The Unaudited Standalone And …

BSE India

Lupin Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 ,inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter Ended June 30, 2026.

21 Jul 2026

2370.50

-1.08%

Lupin spins out 2 cancer drug programmes into US-based Kaveri Therapeutics

Business Standard

New company to raise capital for global clinical trials; Lupin to retain significant equity stake and provide seed funding

Lupin Ltd. is trading above its 200 day SMA of 2208.6

Lupin spins out two cancer drug programmes to new US venture for $1.6 million stake

Business Line | 21 Jul 2026

21 Jul 2026

2370.50

-1.08%

Company Update

Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Acquisition

BSE India

Lupin Inc. U.S.A., wholly owned subsidiary of the Company has entered into a licensing agreement in exchange of 332,000 Common Shares of Kaveri Therapeutics, Inc. U.S.A.

14 Jul 2026

2370.50

-1.08%

Company Update

Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Copy of Newspaper Advertisement relating to Annual General Meeting and e-voting related information.

14 Jul 2026

2370.50

-1.08%

Company Update

Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Lupin Recognized Among India''s Best Employers in the Nation-Builders Category by Great Place to Work India 2026.

13 Jul 2026

2370.50

-1.08%

Corp. Note

Lupin Ltd - 500257 - Business Responsibility and Sustainability Reporting (BRSR)

BSE India

Business Responsibility and Sustainability Report of the Company for FY 2025-26.

13 Jul 2026

2370.50

-1.08%

Corp. Note

Lupin Ltd - 500257 - Reg. 34 (1) Annual Report.

BSE India

Integrated Report of the Company for FY 2025-26.

13 Jul 2026

2370.50

-1.08%

AGM

Lupin Ltd - 500257 - Notice Of The Forty-Fourth Annual General Meeting Of The Company And …

BSE India

Notice of the Forty-Fourth Annual General Meeting of the Company and Integrated Report for FY 2025-26.

09 Jul 2026

2370.50

-1.08%

Company Update

Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Copy of Newspaper Advertisement relating to Annual General Meeting, Record Date and other related information.

Is Lupin Ltd. worth buying?

943 Votes:

Buy 73.06%

Sell 17.39%

Hold 9.54%

RESEARCH REPORTS

Buy SEE REPORTS >

Hold SEE REPORTS >